Risk Factors and Characteristics of the Recurrence of Juvenile Nasopharyngeal Angiofibroma: A 22-Year Experience With 123 Cases at a Tertiary Center
Open Access
- 16 September 2022
- journal article
- research article
- Published by Korean Society of Otorhinolaryngology-Head and Neck Surgery in Clinical and Experimental Otorhinolaryngology
- Vol. 15 (4) , 364-371
Abstract
Objectives. Despite the efficacy of surgical treatments, the high rate of recurrence in juvenile nasopharyngeal angiofibroma (JNA) after surgery remains an unresolved problem. The present study comprehensively analyzed the risk factors and characteristics of JNA recurrence, providing clinical guidance for reducing recurrence.Methods. A total of 123 patients who underwent surgery for JNA between 1997 and 2019 at a single hospital were analyzed retrospectively. Univariate and multivariate analyses were used to assess the clinical risk factors for the recurrence of JNA. The relapse-free survival and annual cumulative recurrence rates were analyzed for subgroups defined according to clinical parameters.Results. After screening, 78 of the 123 patients were included in the present study. The main risk factors associated with JNA recurrence included the year of diagnosis, tumor size, sphenoid bone invasion, Radkowski stage, surgical approach, and intraoperative bleeding. Importantly, the surgical approach and sphenoid bone invasion were independent prognostic factors affecting recurrence. Patients who underwent endoscopic surgery without sphenoid bone invasion exhibited longer relapse-free survival. In the present study, the overall cumulative recurrence rate of JNA was 38.7%, and recurrence occurred mainly in the first year after the initial surgery.Conclusion. Endoscopic surgery achieved better relapse-free survival in JNA patients, and patients with sphenoid bone invasion should be carefully explored to avoid residual JNA. The recurrence rate of JNA differed among subgroups defined based on clinical parameters and was highest in the first year after surgery. Computed tomography or magnetic resonance imaging, along with close follow-up, should be performed strictly within 1 year after the primary operation.Keywords
Funding Information
- National Natural Science Foundation of China (201704020098)
This publication has 27 references indexed in Scilit:
- Juvenile nasopharyngeal angiofibroma: A Systematic Review and Comparison of Endoscopic, Endoscopic‐Assisted, and Open Resection in 1047 CasesThe Laryngoscope, 2013
- Juvenile Angiofibroma: Evolution of ManagementInternational Journal of Pediatrics, 2011
- Current Management of Juvenile Nasopharyngeal Angiofibroma: A Tertiary Center Experience 1999–2007American Journal of Rhinology & Allergy, 2009
- Juvenile Nasopharyngeal Angiofibroma: The Expanded Endonasal ApproachAmerican Journal of Rhinology & Allergy, 2009
- Juvenile nasopharyngeal angiofibroma: Clinical factors associated with recurrence and proposal of a staging systemJournal of Surgical Oncology, 2008
- MANAGEMENT OF INVASIVE JUVENILE NASOPHARYNGEAL ANGIOFIBROMASNeurosurgery, 2007
- An audit of nasopharyngeal fibromasEuropean Journal of Surgical Oncology, 2007
- Recurrence and Its Avoidance in Juvenile AngiofibromaThe Laryngoscope, 2001
- Importance of pre-operative embolization in the surgery of nasopharyngeal angiofibromaIndian Journal of Otolaryngology and Head & Neck Surgery, 1998
- Angiofibroma: Changes in Staging and TreatmentJAMA Otolaryngology–Head & Neck Surgery, 1996